Literature DB >> 8698497

Molecular cloning and characterization of Coccidioides immitis antigen 2 cDNA.

Y Zhu1, C Yang, D M Magee, R A Cox.   

Abstract

Previous experiments have provided evidence that Coccidioides immitis antigen 2 (Ag2) is a major T-cell-reactive component of mycelia and spherule cell walls. Here we report the identification and cloning of the cDNA that encodes Ag2 from a lambda ZAP cDNA expression library constructed from spherule-derived RNA. DNA sequence analysis established that the 1,255-bp clone contains a 174-bp 5' untranslated region, a 582-bp open reading frame which encodes for a protein consisting of 194 amino acids, and a 375-bp 3' untranslated region, including a poly(A) tail. The recombinant Ag2 protein has a predicted molecular mass of 19.5 kDa and contains an 18-amino-acid N terminus which has been tentatively identified as a signal peptide. The Ag2 cDNA was ligated into the pGEX-4T-3 vector and expressed in Escherichia coli TG-1 cells as a glutathione S-transferase fusion protein. The recombinant fusion protein showed reactivity with sera from patients with coccidioidomycosis and elicited delayed-type footpad hypersensitivity responses in Coccidioides-immune mice. These results suggest that the Ag2 cDNA can be used for the large-scale production of this immunologically important protein.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8698497      PMCID: PMC174128          DOI: 10.1128/iai.64.7.2695-2699.1996

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  24 in total

1.  Spectrum of in vivo and in vitro cell-mediated immune responses in coccidioidomycosis.

Authors:  R A Cox; J R Vivas
Journal:  Cell Immunol       Date:  1977-06-01       Impact factor: 4.868

2.  A new method for predicting signal sequence cleavage sites.

Authors:  G von Heijne
Journal:  Nucleic Acids Res       Date:  1986-06-11       Impact factor: 16.971

Review 3.  Coccidioidomycosis. Part I.

Authors:  D J Drutz; A Catanzaro
Journal:  Am Rev Respir Dis       Date:  1978-03

Review 4.  Compilation of published signal sequences.

Authors:  M E Watson
Journal:  Nucleic Acids Res       Date:  1984-07-11       Impact factor: 16.971

5.  A putative signal peptidase recognition site and sequence in eukaryotic and prokaryotic signal peptides.

Authors:  D Perlman; H O Halvorson
Journal:  J Mol Biol       Date:  1983-06-25       Impact factor: 5.469

6.  Antigenic heterogeneity of an alkali-soluble, water-soluble cell wall extract of Coccidioides immitis.

Authors:  R A Cox; L A Britt
Journal:  Infect Immun       Date:  1985-11       Impact factor: 3.441

7.  Coccidioides immitis vaccine: potential of an alkali-soluble, water-soluble cell wall antigen.

Authors:  G Lecara; R A Cox; R B Simpson
Journal:  Infect Immun       Date:  1983-01       Impact factor: 3.441

8.  Delayed-type hypersensitivity responses to a cell wall fraction of the mycelial phase of Coccidioides immitis.

Authors:  E R Ward; R A Cox; J A Schmitt; M Huppert; S H Sun
Journal:  Infect Immun       Date:  1975-11       Impact factor: 3.441

9.  Roles of gamma interferon and interleukin-4 in genetically determined resistance to Coccidioides immitis.

Authors:  D M Magee; R A Cox
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

10.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

View more
  14 in total

1.  Coadministration of interleukin 12 expression vector with antigen 2 cDNA enhances induction of protective immunity against Coccidioides immitis.

Authors:  C Jiang; D M Magee; R A Cox
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

Review 2.  Measurement of cellular immunity in human coccidioidomycosis.

Authors:  Neil M Ampel
Journal:  Mycopathologia       Date:  2003       Impact factor: 2.574

3.  Evaluation of the proline-rich antigen of Coccidioides immitis as a vaccine candidate in mice.

Authors:  T N Kirkland; F Finley; K I Orsborn; J N Galgiani
Journal:  Infect Immun       Date:  1998-08       Impact factor: 3.441

4.  Genetic vaccination against Coccidioides immitis: comparison of vaccine efficacy of recombinant antigen 2 and antigen 2 cDNA.

Authors:  C Jiang; D M Magee; T N Quitugua; R A Cox
Journal:  Infect Immun       Date:  1999-02       Impact factor: 3.441

5.  Identification of a Coccidioides immitis antigen 2 domain that expresses B-cell-reactive epitopes.

Authors:  Y Zhu; V Tryon; D M Magee; R A Cox
Journal:  Infect Immun       Date:  1997-08       Impact factor: 3.441

6.  Resistance to Coccidioides immitis in mice after immunization with recombinant protein or a DNA vaccine of a proline-rich antigen.

Authors:  R O Abuodeh; L F Shubitz; E Siegel; S Snyder; T Peng; K I Orsborn; E Brummer; D A Stevens; J N Galgiani
Journal:  Infect Immun       Date:  1999-06       Impact factor: 3.441

7.  Protection of mice against Coccidioides immitis intranasal infection by vaccination with recombinant antigen 2/PRA.

Authors:  Lisa Shubitz; Tao Peng; Robert Perrill; Julie Simons; Kris Orsborn; John N Galgiani
Journal:  Infect Immun       Date:  2002-06       Impact factor: 3.441

Review 8.  Prospects for the development of fungal vaccines.

Authors:  G S Deepe
Journal:  Clin Microbiol Rev       Date:  1997-10       Impact factor: 26.132

Review 9.  Coccidioidomycosis: host response and vaccine development.

Authors:  Rebecca A Cox; D Mitchell Magee
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

10.  Role of signal sequence in vaccine-induced protection against experimental coccidioidomycosis.

Authors:  Chengyong Jiang; D Mitchell Magee; F Douglas Ivey; Rebecca A Cox
Journal:  Infect Immun       Date:  2002-07       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.